Bristol-Myers Squibb (BMY) Tops Q3 EPS by 4c; Boosts FY15 EPS Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $55.53 +1.52%
Revenue Growth %: -4.6%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: -4.6%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q3 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $4.07 billion versus the consensus estimate of $3.83 billion.
Guidance:
Bristol-Myers Squibb sees FY2015 EPS of $1.85-$1.90, versus the consensus of $1.84.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Green Dot and CommerceOne shareholders approve acquisition deal
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot Guidance, Trader TalkRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
